| Literature DB >> 32709064 |
Toshitaka Yamakawa1,2, Miho Miyajima3, Koichi Fujiwara4, Manabu Kano5, Yoko Suzuki3, Yutaka Watanabe6, Satsuki Watanabe7,8, Tohru Hoshida9, Motoki Inaji10, Taketoshi Maehara10.
Abstract
A warning prior to seizure onset can help improve the quality of life for epilepsy patients. The feasibility of a wearable system for predicting epileptic seizures using anomaly detection based on machine learning is evaluated. An original telemeter is developed for continuous measurement of R-R intervals derived from an electrocardiogram. A bespoke smartphone app calculates the indices of heart rate variability in real time from the R-R intervals, and the indices are monitored using multivariate statistical process control by the smartphone app. The proposed system was evaluated on seven epilepsy patients. The accuracy and reliability of the R-R interval measurement, which was examined in comparison with the reference electrocardiogram, showed sufficient performance for heart rate variability analysis. The results obtained using the proposed system were compared with those obtained using the existing video and electroencephalogram assessments; it was noted that the proposed method has a sensitivity of 85.7% in detecting heart rate variability change prior to seizures. The false positive rate of 0.62 times/h was not significantly different from the healthy controls. The prediction performance and practical advantages of portability and real-time operation are demonstrated in this study.Entities:
Keywords: electrocardiography; epilepsy; heart rate variability; machine learning; multivariate statistical process control; seizure prediction; wearable system
Mesh:
Year: 2020 PMID: 32709064 PMCID: PMC7411877 DOI: 10.3390/s20143987
Source DB: PubMed Journal: Sensors (Basel) ISSN: 1424-8220 Impact factor: 3.576
Figure 1System overview and signal processing workflow of the proposed epileptic seizure prediction system.
Figure 2(a) Block diagram and (b) image of the proposed RRI telemeter. (c) Screenshot of the developed Android app showing memo buttons; current heart rate appears on the heart while monitoring. Instrumentation amplifier (Inst. Amp), analog-to-digital converter (ADC), receiver and transmitter (Rx/Tx).
Patient demographic and clinical characteristics. Medications were carbamazepine (CBZ), gabapentin (GBP), levetiracetam (LEV), valproic acid (VPA), rufinamide (RFN), lamotrigine (LTG), clonazepam (CZP), zonisamide (ZNS), and lacosamide (LCM).
| Patient | Sex | Age | Seizure Foci | Medication (mg/day) |
|---|---|---|---|---|
| A | F | 31 | Right temporal lobe | CBZ 200, GBP 1200 |
| B | M | 54 | Left mesial temporal lobe | LEV 500, VPA 1000 |
| C | M | 20 | Left temporal lobe | LEV 1000 |
| D | F | 25 | Undefined | RFN 600, LTG 150, LEV 2500, VPA 400 |
| E | F | 42 | Occipital lobe (undefined lateralization) | LEV 2000, GBP 600, CZP 1, ZNS 300 |
| F | M | 9 | Right frontal lobe | VPA 400, CBZ 200 |
| G | F | 14 | Undefined | LEV 1750, LCM 50 |
Collected episodes. Seizures were focal-impaired awareness seizures (FIAS), focal to bilateral tonic–clonic seizures (FBTCS), and focal aware seizures (FAS). “FIAS→FBTCS” means that FIAS symptomatically changed to FBTCS, which was treated as a consecutive seizure.
| Patient | Seizures | Total Duration (h:min) | Interictal Duration (h:min) | Control (age/gender) | Total Duration (h:min) |
|---|---|---|---|---|---|
| A | 3 FIAS | 70:14 | 0:53 | 31/F | 5:08 |
| B | FIAS→FBTCS | 40:35 | 13:47 | 57/M | 4:48 |
| C | 2 FIAS | 32:18 | 9:21 | 20/M | 7:17 |
| D | FIAS | 105:52 | 2:57 | 25/F | 7:08 |
| E | 2 FAS | 85:03 | 2:43 | 45/F | 11:21 |
| F | 2 FIAS | 28:39 | 8:07 | 9/M | 6:07 |
| G | 3 FAS | 86:45 | 2:28 | 16/F | 7:14 |
Figure 3Bland–Altman plot comparing the RRIs obtained from the reference ECG and the proposed system. The measurement bias indicated by the dashed-line and the stochastic error range indicated by the solid lines defined by the limits of agreement are sufficiently low for HRV analysis. No significant proportional bias is observed in the result of the regression analysis of this plot.
Measured failure rate for all subjects.
| Patient | Total RRIs | RRI Outliers | Failure Rate (%) |
|---|---|---|---|
| A | 245,920 | 11,564 | 4.7 |
| B | 163,520 | 577 | 0.4 |
| C | 159,240 | 5805 | 3.6 |
| D | 474,630 | 31,665 | 6.7 |
| E | 343,770 | 14,668 | 4.3 |
| F | 144,530 | 2446 | 1.7 |
| G | 419,440 | 11,866 | 2.8 |
Seizure prediction performance. The duration of prediction is shown with the start and the end of exceedance (e.g., −05:28 to −05:17) means that the statistic exceeded the control limit from 5 min 28 sec to 5 min 17 sec prior to a seizure. NA indicates not available, meaning that the statistic did not exceed the control limit. Sen (sensitivity) summarizes the true positive ratio of seizure prediction.
| Seizure | Duration (min:s to min:s) | |
|---|---|---|
|
|
| |
|
| −05:10 to −04:58 | NA |
|
| −05:16 to −02:19 | NA |
|
| NA | NA |
|
| −07:06 to −05:16 | NA |
|
| −14:40 to −14:25, −12:41 to −11:40 | NA |
|
| NA | −09:56 to −08:16 |
|
| −13:05 to −11:15 | NA |
|
| −16:09 to −14:44, −09:36 to −06:39 | NA |
|
| −14:43 to −10:36 | NA |
|
| −12:43 to −12:06 | −13:18 to −10:28, −06:34 to −02:52 |
|
| −15:41 to −12:42, −10:13 to −08:44 | NA |
|
| −14:23 to −13:39, −08:37 to −04:54, −03:38 to −01:05 | NA |
|
| −03:52 to −02:59 | NA |
|
| −12:18 to −09:33 | NA |
|
| 85.7% | 14.3% |
Figure 4Results of MSPC analysis for seizure episodes (a) A1 and (b) B1. The horizontal lines and vertical lines indicate the control limits and the seizure onset, respectively. The colored bands denote , indicating the discriminated preictal change.
Figure 5Result of MSPC analysis for the interictal episodes of (a) patient A, selected to include false positives; and (b) patient B, without the false positives.
False positive rate during interictal period.
| Patient | False Positive Rate (times/h) | False Positive Rate of Healthy Control | ||
|---|---|---|---|---|
|
|
|
|
| |
|
| 3.34 | 1.11 | 0 | 2.14 |
|
| 0.29 | 1.16 | 0 | 1.46 |
|
| 1.62 | 1.62 | 0.69 | 1.92 |
|
| 0.43 | 1.71 | 0.14 | 0.56 |
|
| 0.67 | 0.34 | 1.32 | 0.59 |
|
| 0.73 | 4.76 | 1.30 | 0.65 |
|
| 0.74 | 0.37 | 0.97 | 1.82 |
|
| 0.62 | 1.34 | 0.93 | 1.02 |